Position in GILD
as of Mar 31, 2026
· filed Apr 22, 2026
Position Value
$298,251
-$58,185 QoQ
Shares Held
2,140
-26.3% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.12%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Common Shares in GILD Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026TRAPHAGEN INVESTMENT ADVISORS LLC holds $8,468,712 across 7 Drug Manufacturers - General names.
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
9,821 | $2,494,239 | |
| 2 | ABBV |
AbbVie Inc.
|
9,472 | $2,383,534 | |
| 3 | LLY |
ELI LILLY & Co
|
1,286 | $1,542,467 | |
| 4 | MRK |
Merck & Co., Inc.
|
6,280 | $806,980 | |
| 5 | PFE |
Pfizer Inc
|
22,620 | $544,689 | |
| 6 | AMGN |
Amgen Inc
|
1,367 | $495,018 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
3,502 | $201,785 |
All Filings in GILD
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $298,251 | 2,140 | Shares | Sole | 2026-04-22 | |
| 2025-12-31 | $356,436 | 2,904 | Shares | Sole | 2026-01-27 | |
| 2025-09-30 | $319,236 | 2,876 | Shares | Sole | 2025-10-07 | |
| 2025-06-30 | $317,864 | 2,867 | Shares | Sole | 2025-07-23 | |
| 2025-03-31 | $322,479 | 2,878 | Shares | Sole | 2025-04-17 | |
| 2024-12-31 | $264,824 | 2,867 | Shares | Sole | 2025-01-17 | |
| 2024-09-30 | $240,453 | 2,868 | Shares | Sole | 2024-10-21 | |
| 2024-06-30 | $208,299 | 3,036 | Shares | Sole | 2024-07-23 | |
| 2024-03-31 | $222,240 | 3,034 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $231,040 | 2,852 | Shares | Sole | 2024-06-17 | |
| 2023-09-30 | $213,653 | 2,851 | Shares | Sole | 2024-06-17 | |
| 2023-06-30 | $219,726 | 2,851 | Shares | Sole | 2024-06-17 | |
| 2023-03-31 | $236,464 | 2,850 | Shares | Sole | 2024-06-17 | |
| 2022-12-31 | $244,672 | 2,850 | Shares | Sole | 2024-06-17 | |
| 2022-09-30 | $24,265,514 | 393,346 | Shares | Sole | 2024-06-17 | |
| 2022-06-30 | $15,989,319 | 258,685 | Shares | Sole | 2024-06-17 | |
| 2022-03-31 | $6,359,485 | 106,972 | Shares | Sole | 2024-06-17 | |
| 2021-12-31 | $10,370,377 | 142,823 | Shares | Sole | 2024-06-17 | |
| 2021-09-30 | $11,391,416 | 163,084 | Shares | Sole | 2024-06-17 | |
| 2021-06-30 | $11,011,540 | 159,912 | Shares | Sole | 2024-06-17 | |
| 2021-03-31 | $9,480,897 | 146,695 | Shares | Sole | 2024-06-17 | |
| 2020-12-31 | $12,276,955 | 210,727 | Shares | Sole | 2024-06-17 | |
| 2020-09-30 | $12,230,803 | 193,556 | Shares | Sole | 2024-06-17 | |
| 2020-06-30 | $229,204 | 2,979 | Shares | Sole | 2024-06-17 | |
| 2020-03-31 | $222,635 | 2,978 | Shares | Sole | 2024-06-17 | |
| No filing history on record for this holder in this stock. | ||||||